Atlas Trials

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

Clinical trial NCT00136539 · COMPLETED

Trial details

NCT number
NCT00136539
Sponsor
Harold J. Burstein, MD, PhD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
1999-03-01
Primary completion
2006-11-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.